| # | Name | Description | Category | Type | Source | Website |
|---|
| # | Opportunity | Type | Region / Country | Amount | Deadline | Source |
|---|---|---|---|---|---|---|
| 43876 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nintedanib (OFEV und Generika), ATC L01EX09 für die Zeit 01.05.26-30.04.28 (zzgl. V.-Option 1x12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 |
||||||
| 43877 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Megestrol, ATC L02AB01 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 |
||||||
| 43878 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Chlortalidon, ATC C03BA04 für die Zeit 01.05.26-30.04.28 (zzgl. V.-Option 1x12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 |
||||||
| 43879 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ciclopirox, ATC D01AE14 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 |
||||||
| 43880 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dydrogesteron + Estrogen, ATC G03FB08 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 |
||||||
| 43881 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Glyceroltrinitrat, ATC C05AE01 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 |
||||||
| 43882 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Estradiol (ausschl. DaFo GEL), ATC G03CA03 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 |
||||||
| 43883 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Diltiazem, ATC C08DB01 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 |
||||||
| 43884 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Moxifloxacin, ATC S01AE07 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 |
||||||
| 43885 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Enalapril (ohne 2,5 mg + 5 mg), ATC C09AA02 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 |
||||||
| 43886 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clindamycin (ausschl. DaFo VSU), ATC G01AA10 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 |
||||||
| 43887 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pimecrolimus, ATC D11AH02 für die Zeit 01.05.26 - 30.04.28 (zzgl. V.-Option 1x12 Monate) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-03-05 |
||||||
| 43888 | Sweden – Procurement consultancy services – Upphandlingskonsulter Buyer: REGION HALLAND | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2029-03-05 | Tender Procurement Contract | Sweden | Not provided on the source page. Please check the official source. | Open Mar 5, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: REGION HALLAND | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2029-03-05 |
||||||
| 43889 | Bulgaria – Pharmaceutical products – Динамичната система за покупки (ДСП) - Доставка на лекарствени продукти Buyer: Многопрофилна болница за активно лечение "Национална кардиологична болница" ЕАД | Notice type: cn-standard | Procedure: res... | Tender Procurement Contract | Bulgaria | Not provided on the source page. Please check the official source. | Open Mar 5, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Многопрофилна болница за активно лечение "Национална кардиологична болница" ЕАД | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-03-05 |
||||||
| 43890 | Norway – Research and development services and related consultancy services – Dynamic procurement scheme for biology and popular science assistance. Buyer: ARTSDATABANKEN | Notice type: cn-standard | Procedure: oth-mult | Contract: services | Deadline: 2029-03-05 | Tender Procurement Contract | Norway | Not provided on the source page. Please check the official source. | Open Mar 5, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: ARTSDATABANKEN | Notice type: cn-standard | Procedure: oth-mult | Contract: services | Deadline: 2029-03-05 |
||||||
| 43891 | Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional) The National Library of Medicine (NLM) seeks applications for research projects that drive groundbreaking innovation and advanced... | Grant Cash Grant | United States | Award ceiling: $250,000 | Open Mar 5, 2029 Open | Grants.gov |
|
Source description
The National Library of Medicine (NLM) seeks applications for research projects that drive groundbreaking innovation and advanced development in the fields of bioinformatics, translational bioinformatics, and computational biology. The primary goal of this initiative is to support the creation and implementation of cutting-edge methods, tools, and approaches that can transform the landscape of biomedical data science. This NOFO aims to address the growing need to leverage transformative technologies — such as artificial intelligence (AI), machine learning, and large-scale computational platforms — to extract actionable knowledge from vast, diverse, and complex biological datasets. By enabling more effective interpretation and integration of multi-dimensional biological and biomedical data, this research will ultimately contribute to improving individual and population health outcomes. |
||||||
| 43892 | Research Grants in Clinical Informatics (R01 Clinical Trial Optional) The National Library of Medicine (NLM) seeks applications for innovative research in clinical informatics. The overarching goal of... | Grant Cash Grant | United States | Award range: $0 - $250,000 | Open Mar 5, 2029 Open | Grants.gov |
|
Source description
The National Library of Medicine (NLM) seeks applications for innovative research in clinical informatics. The overarching goal of this forthcoming program is to catalyze the development and advancement of novel informatics methodologies that empower clinicians, patients, and the broader public to better understand, manage, and improve health and health care delivery. This NOFO will support research focused on the design, implementation, and evaluation of clinical informatics tools and methods that enable data-driven discovery, promote evidence-based decision-making, and support personalized and precision health care. Emphasis will be placed on domain-independent, scalable, and reusable/reproducible approaches for the discovery, analysis, organization, and management of health-related digital objects—including electronic health records (EHRs), clinical notes, imaging data, and patient-generated data. The aim is to transform raw and heterogeneous health data into actionable knowledge, to develop innovative tools, and to implement practical applications that can be generalized across multiple clinical settings and populations. Projects should demonstrate the potential to accelerate scientific insights, improve clinical workflows, and ultimately lead to improved health outcomes. |
||||||
| 43893 | France – Motor vehicles – Acquisition, location et maintenance de véhicules pour le GHT santé 41 Buyer: CH Blois Etablissement support du GHT Santé 41 | Notice type: cn-standard | Procedure: restricted | Contract: supplies | De... | Tender Procurement Contract | France | Not provided on the source page. Please check the official source. | Open Mar 6, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: CH Blois Etablissement support du GHT Santé 41 | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-03-06 |
||||||
| 43894 | Netherlands – Supply services of personnel including temporary staff – Instellen Dynamisch Aankoopsysteem Buyer: Het Industrieschap "De Plaspoelpolder" | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline:... | Tender Procurement Contract | Netherlands | Not provided on the source page. Please check the official source. | Open Mar 6, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Het Industrieschap "De Plaspoelpolder" | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2029-03-06 |
||||||
| 43895 | Lithuania – Snow-clearing services – 25086 Geležinkelio stočių centralizuotų bei rankinių iešmų, įskaitant ir pervažų teritorijas, valymo nuo sniego ir ledo paslaugos Buyer: AB "Lietuvos geležinkeliai" | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2029-03-07 | Tender Procurement Contract | Lithuania | Not provided on the source page. Please check the official source. | Open Mar 7, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AB "Lietuvos geležinkeliai" | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2029-03-07 |
||||||
| 43896 | F24AS00298 Cooperative Agriculture The objectives for the use of cooperative agriculture in the National Wildlife Refuge System (NWRS) are: production or modificatio... | Grant Mixed | United States | Award range: $0 - $0 | Open Mar 7, 2029 Open | Grants.gov |
|
Source description
The objectives for the use of cooperative agriculture in the National Wildlife Refuge System (NWRS) are: production or modification of specific cover types or growing methods that meet the life history requirements of species for which we have established objectives (e.g., waterfowl production); production of foods for wildlife species for which we have established objectives; and/or maintenance, rehabilitation, or reestablishment of natural habitat. Cooperative agriculture is when a person or entity conducts agricultural practices on NWRS lands in support of the Service’s conservation and resource management objectives and there is substantial involvement between the Service and that person or entity. The NWRS uses cooperative agreements, known as Cooperative Agriculture Agreements (CAAs), as the legal instruments to formalize the agreement between the Service and the program participant. The cost-sharing of a person or entity in cooperative agricultural on NWRS lands can vary depending on the needs and objectives of the particular NWRS land. For example, the Service may provide the cooperator with the right to perform agricultural practices on NWRS land and a percentage of any resulting crop yield, as well as the ability to use Service water, equipment, and/or refuge staff. In exchange, the cooperator may provide the Service with labor, equipment, and materials; a percentage of any resulting crop yield; and/or maintenance, rehabilitation, or reestablishment of specific habitat conditions on NWRS lands. In addition to or instead of cost-sharing, the Service may accept bids... |
||||||
| 43897 | Bulgaria – Pharmaceutical products – ДОСТАВКА НА ОБИЧАЙНО ИЗПОЛЗВАНИ ЛЕКАРСТВЕНИ ПРОДУКТИ, НЕОБХОДИМИ ЗА ДЕЙНОСТТА НА УМБАЛ „ПРОФ. Д-Р СТОЯН КИРКОВИЧ“ АД“ Buyer: УНИВЕРСИТЕТСКА МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ - ПРОФ. Д-Р СТОЯН КИРКОВИЧ АД | Notice type: cn-standard | Procedur... | Tender Procurement Contract | Bulgaria | Not provided on the source page. Please check the official source. | Open Mar 9, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: УНИВЕРСИТЕТСКА МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ - ПРОФ. Д-Р СТОЯН КИРКОВИЧ АД | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-03-09 |
||||||
| 43898 | Bulgaria – Pharmaceutical products – ДОСТАВКА НА ОБИЧАЙНО ИЗПОЛЗВАНИ ЛЕКАРСТВЕНИ ПРОДУКТИ, НЕОБХОДИМИ ЗА ДЕЙНОСТТА НА УМБАЛ „ПРОФ. Д-Р СТОЯН КИРКОВИЧ“ АД“ Buyer: УНИВЕРСИТЕТСКА МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ - ПРОФ. Д-Р СТОЯН КИРКОВИЧ АД | Notice type: cn-standard | Procedur... | Tender Procurement Contract | Bulgaria | Not provided on the source page. Please check the official source. | Open Mar 9, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: УНИВЕРСИТЕТСКА МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ - ПРОФ. Д-Р СТОЯН КИРКОВИЧ АД | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-03-09 |
||||||
| 43899 | France – Motor vehicles – Acquisition de véhicules neufs et d'occasion pour les besoins de la communauté d'agglomération Plaine Vallée Buyer: Communauté d'agglomération Plaine Vallée | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline... | Tender Procurement Contract | France | Not provided on the source page. Please check the official source. | Open Mar 10, 2029 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Communauté d'agglomération Plaine Vallée | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-03-10 |
||||||
| 43900 | Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed) The goal of the Paul Calabresi Career Development Award for Clinical Oncology (PCACO) is to increase the number of clinician-scien... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Mar 12, 2029 Open | Grants.gov |
|
Source description
The goal of the Paul Calabresi Career Development Award for Clinical Oncology (PCACO) is to increase the number of clinician-scientists trained in clinical and translational cancer research, and to promote their career development as cancer researchers. This Notice of Funding Opportunity (NOFO) does not allow Scholars to propose to lead an independent clinical trial, but does allow Scholars to propose research experience in a clinical trial led by a mentor or co-mentor. |
||||||